(Q38352155)

English

How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

0 references

2

object named as

Uffe Ravnskov

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

David M Diamond

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

12 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Expert Review of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

201-210

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

The cholesterol controversy is over. Why did it take so long?

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

In celebration of the 100th anniversary of the lipid hypothesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

An elevated serum cholesterol level is secondary, not causal, in coronary heart disease

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Dietary lipids and coronary heart disease: old evidence, new perspective

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

A hypothesis out-of-date. the diet-heart idea

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

An epidemic of coronary heart disease.

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Is atherosclerosis caused by high cholesterol?

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Cholesterol does not cause coronary heart disease in contrast to stress

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

The cholesterol hypothesis: time for the obituary?

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Lower patients' cholesterol now

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

What are the odds at ASCOT today?

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Two decades of progress in preventing vascular disease

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Age-related cataract is associated with type 2 diabetes and statin use.

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Statins and the risk of new-onset diabetes: a review of recent evidence

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Statin-associated adverse cognitive effects: survey results from 171 patients.

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Do statins decrease cardiovascular disease at the expense of increasing cancer?

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Virus induced inflammation and cancer development

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

The statin-low cholesterol-cancer conundrum

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Cholesterol-lowering and cancer in the prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Carcinogenicity of lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Statins and activity: proceed with caution.

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Muscular side effects of statins

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Statin-associated myopathy with normal creatine kinase levels

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Cholesterol and mental disorder

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Cholesterol and the "Cycle of Violence" in attempted suicide.

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk.

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Low cholesterol level in patients with panic disorder: the association with major depression

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Serum lipid levels, suicidality, and panic disorder

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Association between total serum cholesterol and depression, aggression, and suicidal ideations in war veterans with posttraumatic stress disorder: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Lipophilic statin use and suicidal ideation in a sample of adults with mood disorders

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Low serum cholesterol is correlated to suicidality in a Korean sample

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Alzheimer disease--no target for statin treatment. A mini review

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study.

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Statins and risk of polyneuropathy: a case-control study

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Half of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Medical journals and industry ties

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

The negative effects of hydrogenated trans fats and what to do about them

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Saturated fat and health: recent advances in research

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Saturated fat, carbohydrate, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

The questionable benefits of exchanging saturated fat with polyunsaturated fat.

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2015.1012494

21 January 2018

Identifiers

10.1586/17512433.2015.1012494

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38352155&oldid=2126310104"